Merck makes a big move into new cancer treatments with a $6.7 billion
buyout deal
-
Merck to spend $6.7 billion to buy Terns Pharmaceuticals, which is
developing an oral treatment for leukemia.
53 minutes ago







Premesh Chandran, CEO of Malaysiakini, said: "I think it was an excellent coverage by the international media of the rally, I think it raises a lot of question. Malaysia is the member of the Human Rights Council, it has committed itself to freedom of expression, freedom of assembly. And yet, if you look at the practice on the ground, it's not the case."
ReplyDelete